Medicare Enrolled

Dr. Sabina Wallach, M.D.

Hematology & Oncology · La Jolla, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
9850 GENESEE AVE, La Jolla, CA 92037
8585588666
In practice since 2006 (19 years)
NPI: 1871529081 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wallach from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wallach? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wallach

Dr. Sabina Wallach is a hematology & oncology specialist in La Jolla, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wallach performed 63,280 Medicare services across 2,684 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wallach received a total of $30,008 from 97 pharmaceutical and/or device companies across 985 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wallach is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 12% volume in CA $30,008 industry payments

Medicare Practice Summary

Medicare Utilization ↗
63,280
Medicare services
Top 12% in CA for hematology & oncology
2,684
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,331 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Injectafer)
An intravenous injection of ferric carboxymaltose, an iron replacement medication.
21,000 $1 $4
Denosumab injection (Prolia/Xgeva) 16,200 $18 $80
Romosozumab injection (Evenity) for osteoporosis 11,970 $8 $30
Epoetin alfa injection (Retacrit) for anemia
An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units.
5,541 $6 $25
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
1,382 $8 $30
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
1,320 $8 $14
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
1,220 $10 $50
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,117 $104 $200
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
715 $12 $45
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
547 $142 $250
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
290 $7 $150
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
232 $0 $25
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
175 $56 $250
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
171 $120 $300
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
157 $1 $10
Quadrivalent influenza vaccine, cell-culture derived
A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics.
133 $33 $50
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
133 $33 $45
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
124 $11 $30
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
119 $8 $50
Lactate dehydrogenase (LDH) level test
A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease.
118 $6 $15
Manual urinalysis with microscopic examination
A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities.
110 $4 $25
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
104 $26 $90
Magnesium level test
A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess.
85 $7 $41
Normal saline infusion, 500 ml
Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution.
82 $1 $25
New patient office visit, complex (60-74 min) 76 $162 $400
Pneumococcal conjugate vaccine (PCV20)
An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria.
45 $281 $350
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
45 $33 $45
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
33 $70 $100
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $77 $150
Transitional care management, high complexity
Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem.
14 $232 $520
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
34.4% high complexity
55.1% medium
10.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$30,008
Total received (2018-2024)
Avg $4,287/year across 7 years
Top 16% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
97
Companies
985
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,343 (67.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,687 (29.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$978 (3.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,065
2023
$4,278
2022
$3,360
2021
$3,598
2020
$6,013
2019
$3,026
2018
$7,668

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$230
Novartis Pharmaceuticals Corporation
$226
Janssen Biotech, Inc.
$137
Lilly USA, LLC
$136
PFIZER INC.
$134
Regeneron Healthcare Solutions, Inc.
$102
AstraZeneca Pharmaceuticals LP
$83
Octapharma USA, Inc.
$77
Takeda Pharmaceuticals U.S.A., Inc.
$71
ABBVIE INC.
$68
Kite Pharma, Inc.
$61
Amgen Inc.
$61
ARRAY BIOPHARMA INC
$55
BeiGene USA, Inc.
$52
Gilead Sciences, Inc.
$51
Dendreon Pharmaceuticals LLC
$48
Verity Pharmaceuticals Inc.
$48
Agios Pharmaceuticals, Inc.
$41
Bayer Healthcare Pharmaceuticals Inc.
$40
Celgene Corporation
$35
Incyte Corporation
$34
PharmaEssentia USA Corporation
$33
TAIHO ONCOLOGY, INC.
$32
Rigel Pharmaceuticals, Inc.
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$29
Alnylam Pharmaceuticals Inc.
$28
PUMA BIOTECHNOLOGY, INC.
$27
E.R. Squibb & Sons, L.L.C.
$23
Mirati Therapeutics, Inc.
$22
GlaxoSmithKline, LLC.
$17
Daiichi Sankyo Inc.
$16
Menarini Silicon Biosystems, Inc.
$15
Top 3 companies account for 28.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$4,091
Kite Pharma, Inc.
$4,027
PFIZER INC.
$1,453
Novartis Pharmaceuticals Corporation
$1,355
Janssen Biotech, Inc.
$1,338
Bayer HealthCare Pharmaceuticals Inc.
$1,273
Puma Biotechnology, Inc.
$1,248
E.R. Squibb & Sons, L.L.C.
$1,046
Amgen Inc.
$1,021
Celgene Corporation
$655
Seagen Inc.
$619
Merck Sharp & Dohme Corporation
$617
Takeda Pharmaceuticals U.S.A., Inc.
$610
Alexion Pharmaceuticals, Inc.
$598
Lilly USA, LLC
$579
Genentech USA, Inc.
$428
Incyte Corporation
$392
Daiichi Sankyo Inc.
$381
Pharmacyclics LLC, An AbbVie Company
$376
Karyopharm Therapeutics Inc.
$319
Rigel Pharmaceuticals, Inc.
$299
Regeneron Healthcare Solutions, Inc.
$288
Myriad Genetic Laboratories, Inc.
$271
Seattle Genetics, Inc.
$256
PUMA BIOTECHNOLOGY, INC.
$254
GlaxoSmithKline, LLC.
$245
BeiGene USA, Inc.
$235
Janssen Pharmaceuticals, Inc
$229
ARRAY BIOPHARMA INC
$224
SOBI, INC
$219
EISAI INC.
$212
Dendreon Pharmaceuticals LLC
$210
Gilead Sciences, Inc.
$208
Pharmacyclics LLC, an AbbVie Company
$199
Coherus Biosciences Inc.
$194
Exelixis Inc.
$191
Bayer Healthcare Pharmaceuticals Inc.
$184
Ipsen Biopharmaceuticals, Inc
$180
Blueprint Medicines Corporation
$174
Astellas Pharma US Inc
$163
EUSA Pharma (US) LLC
$161
Boehringer Ingelheim Pharmaceuticals, Inc.
$159
Teva Pharmaceuticals USA, Inc.
$153
EMD Serono, Inc.
$110
TAIHO ONCOLOGY, INC.
$106
Octapharma USA, Inc.
$101
TESARO, Inc.
$97
Foundation Medicine, Inc.
$92
Eisai Inc.
$89
Clovis Oncology, Inc.
$86
Dova Pharmaceuticals
$86
GENZYME CORPORATION
$81
Otsuka America Pharmaceutical, Inc.
$80
Helsinn Therapeutics (U.S.), Inc.
$77
Sobi, Inc
$73
Mirati Therapeutics, Inc.
$69
ABBVIE INC.
$68
Epizyme, Inc.,
$67
Taiho Oncology, Inc.
$67
Deciphera Pharmaceuticals Inc.
$67
TerSera Therapeutics LLC
$63
RECORDATI_RARE_DISEASES_INC.
$63
MorphoSys, US Inc.
$62
MEDIVATION FIELD SOLUTIONS LLC
$56
ADC Therapeutics America, Inc.
$54
Verastem, Inc.
$49
AbbVie, Inc.
$48
Verity Pharmaceuticals Inc.
$48
Spectrum Pharmaceuticals Inc.
$46
Array BioPharma Inc.
$46
Regeneron Pharmaceuticals, Inc.
$44
Merck Sharp & Dohme LLC
$44
Heron Therapeutics, Inc.
$41
Agios Pharmaceuticals, Inc.
$41
JAZZ PHARMACEUTICALS INC.
$41
AbbVie Inc.
$40
Sirtex Medical Inc
$34
PharmaEssentia USA Corporation
$33
SANOFI PASTEUR INC.
$32
Secura Bio, Inc.
$32
Kyowa Kirin, Inc.
$31
PORTOLA PHARMACEUTICALS, LLC
$30
Amneal Pharmaceuticals LLC
$28
Alnylam Pharmaceuticals Inc.
$28
Acrotech Biopharma Inc.
$24
GE HEALTHCARE
$23
Mylan Institutional Inc.
$23
Genmab U.S., Inc.
$21
Immunomedics, Inc.
$18
Ferring Pharmaceuticals Inc.
$17
Shield Therapeutics Inc
$16
Seqirus USA Inc
$16
INSYS Therapeutics Inc
$15
Menarini Silicon Biosystems, Inc.
$15
Partner Therapeutics, Inc.
$15
Jazz Pharmaceuticals Inc.
$13
Fortovia Therapeutics, Inc.
$13
Top 3 companies account for 31.9% of all-time payments
Associated products mentioned in payments ›
ABECMA · ACCRUFER · ADACEL · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · ANDEXXA · AREXVY · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BENLYSTA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CINVANTI · CYRAMZA · Cabometyx · Cellsearch · Cinvanti · Copiktra · DARZALEX · DOPTELET · DUPIXENT · Doptelet · ELAHERE · ELIQUIS · EMEND · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Epkinly · Erleada · FARESTON · FARYDAK · FIRMAGON · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FOUNDATIONONE · Fabhalta · Farydak · Fluad Quadrivalent · Folotyn · Fulphila · GAUCHER-DISEASE · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · GRANIX · HERZUMA · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LEMTRADA · LENVIMA · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · MEKINIST · MONJUVI · MVASI · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PREVYMIS · PROMACTA · PROVENGE · PYRUKYND · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · REMICADE · RETACRIT · RETEVMO · ROLVEDON · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TRAZIMERA · TUKYSA · Tavalisse · Tazverik · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xofigo · YERVOY · Yescarta · ZEJULA · ZEPZELCA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (68%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in La Jolla?
Compare hematology & oncology specialists in the La Jolla area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
138
Per 100K population
4.2
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL LA JOLLA
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wallach is a mixed practice specialist, with above-average Medicare volume (top 12% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wallach experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Wallach performed 21,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wallach receive payments from pharmaceutical companies?
Yes. Dr. Wallach received a total of $30,008 from 97 companies across 985 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wallach's costs compare to other hematology & oncology specialists in La Jolla?
Dr. Wallach's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wallach) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →